← Back
$TSHA All transactions

Taysha Gene Therapies, Inc.

▼ SELL

$ Value

$190K

Shares

41,312

Price

$5

Filed

Jan 27

Insider

Name

Nolan Sean P.

Title

Chief Executive Officer

CIK

0001569926

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-26

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,908,257

Footnotes

The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive. | The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.

Filing Info

Accession No.

0001569926-26-000008

Form Type

4

Issuer CIK

0001806310

Nolan Sean P.'s History

Date Ticker Type Value
2026-01-26 TSHA $190K
2026-01-23 TSHA $650K
2026-01-12 TSHA A $0
2026-01-12 TSHA A $0
2025-05-13 VTR A $185K

Other Insiders at TSHA (90d)

Insider Bought Sold Last
Nolan Sean P.
Chief Executive Officer
$650K 2026-01-23
Nagendran Sukumar
President and Head of R&D
$1.4M 2026-04-10
Alam Kamran
CHIEF FINANCIAL OFFICER
$493K 2026-02-04